Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 9683053 Hetero-dimeric immunoglobulins

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Date of Patent

June 20, 2017

Patent Application Number

14167712

Date Filed

January 29, 2014

Patent Citations Received

US Patent 12129300 Antibody variable domains targeting the NKG2D receptor

0

US Patent 11932675 PD-1 targeted IL-15/IL-15Rα Fc fusion proteins with improved properties

0

US Patent 11939384 Antibody variable domains targeting the NKG2D receptor

0

US Patent 12006367 CD3/CD38 T cell retargeting hetero-dimeric immunoglobulins and methods of their production

0

US Patent 11773166 CD3/CD38 T cell retargeting hetero-dimeric immunoglobulins and methods of their production

US Patent 11834506 Multi-specific binding proteins that bind NKG2D, CD16, and a tumor-associated antigen for activation of natural killer cells and therapeutic uses thereof to treat cancer

0

US Patent 11879013 Combination therapies with bispecific anti-EGFR/c-Met antibodies and third generation EGFR tyrosine kinase inhibitors

0

US Patent 11884733 Antibody variable domains targeting the NKG2D receptor

0

...

Patent Primary Examiner

Patent abstract

The present invention relates to engineered hetero-dimeric immunoglobulins or fragments thereof and methods of making the same.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9683053 Hetero-dimeric immunoglobulins

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool